GSK3 and tau: Two convergence points in Alzheimer's disease
Glycogen synthase kinase 3 (GSK3) is a ubiquitously expressed serine/threonine kinase that plays a key role in the pathogenesis of Alzheimer's disease (AD). GSK3 phosphorylates tau in most serine and threonine residues hyperphosphorylated in paired helical filaments, and GSK3 activity contribut...
| Autores: | , , |
|---|---|
| Formato: | artículo |
| Fecha de publicación: | 2012 |
| País: | España |
| Recursos: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repositorio: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/115958 |
| Acesso em linha: | http://hdl.handle.net/10261/115958 |
| Access Level: | acceso abierto |
| Palavra-chave: | GSK3 Tau Alzheimer’s disease |
| id |
ES_ae8c3eebbfc493e9b0ec936f4879aec4 |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/115958 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
GSK3 and tau: Two convergence points in Alzheimer's diseaseHernández Pérez, FélixLucas, José JavierÁvila, JesúsGSK3TauAlzheimer’s diseaseGlycogen synthase kinase 3 (GSK3) is a ubiquitously expressed serine/threonine kinase that plays a key role in the pathogenesis of Alzheimer's disease (AD). GSK3 phosphorylates tau in most serine and threonine residues hyperphosphorylated in paired helical filaments, and GSK3 activity contributes both to amyloid-β production and amyloid-β-mediated neuronal death. Thus, mice generated in our laboratory with conditional overexpression of GSK3 in forebrain neurons (Tet/GSK3β mice) recapitulate aspects of AD neuropathology such as tau hyperphosphorylation, apoptotic neuronal death, and reactive astrocytosis, as well as spatial learning deficit. In this review, we describe recent contributions of our group showing that transgene shutdown in that animal model leads to normal GSK3 activity, normal phospho-tau levels, diminished neuronal death, and suppression of the cognitive deficit, thus further supporting the potential of GSK3 inhibitors for AD therapeutics. In addition, we have combined transgenic mice overexpressing the enzyme GSK3β with transgenic mice expressing tau with a triple FTDP-17 mutation that develop prefibrillar tau-aggregates. Our data suggest that progression of the tauopathy can be prevented by administration of lithium when the first signs of neuropathology appear. Further, it is possible to partially reverse tau pathology in advanced stages of the disease, although the presence of already assembled neurofibrillary tangle-like structures cannot be reversed. © 2013 The authors and IOS Press. All rights reserved.Peer Reviewed2015201520122015info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501http://hdl.handle.net/10261/115958reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Inglésinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/1159582026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
GSK3 and tau: Two convergence points in Alzheimer's disease |
| title |
GSK3 and tau: Two convergence points in Alzheimer's disease |
| spellingShingle |
GSK3 and tau: Two convergence points in Alzheimer's disease Hernández Pérez, Félix GSK3 Tau Alzheimer’s disease |
| title_short |
GSK3 and tau: Two convergence points in Alzheimer's disease |
| title_full |
GSK3 and tau: Two convergence points in Alzheimer's disease |
| title_fullStr |
GSK3 and tau: Two convergence points in Alzheimer's disease |
| title_full_unstemmed |
GSK3 and tau: Two convergence points in Alzheimer's disease |
| title_sort |
GSK3 and tau: Two convergence points in Alzheimer's disease |
| dc.creator.none.fl_str_mv |
Hernández Pérez, Félix Lucas, José Javier Ávila, Jesús |
| author |
Hernández Pérez, Félix |
| author_facet |
Hernández Pérez, Félix Lucas, José Javier Ávila, Jesús |
| author_role |
author |
| author2 |
Lucas, José Javier Ávila, Jesús |
| author2_role |
author author |
| dc.subject.none.fl_str_mv |
GSK3 Tau Alzheimer’s disease |
| topic |
GSK3 Tau Alzheimer’s disease |
| description |
Glycogen synthase kinase 3 (GSK3) is a ubiquitously expressed serine/threonine kinase that plays a key role in the pathogenesis of Alzheimer's disease (AD). GSK3 phosphorylates tau in most serine and threonine residues hyperphosphorylated in paired helical filaments, and GSK3 activity contributes both to amyloid-β production and amyloid-β-mediated neuronal death. Thus, mice generated in our laboratory with conditional overexpression of GSK3 in forebrain neurons (Tet/GSK3β mice) recapitulate aspects of AD neuropathology such as tau hyperphosphorylation, apoptotic neuronal death, and reactive astrocytosis, as well as spatial learning deficit. In this review, we describe recent contributions of our group showing that transgene shutdown in that animal model leads to normal GSK3 activity, normal phospho-tau levels, diminished neuronal death, and suppression of the cognitive deficit, thus further supporting the potential of GSK3 inhibitors for AD therapeutics. In addition, we have combined transgenic mice overexpressing the enzyme GSK3β with transgenic mice expressing tau with a triple FTDP-17 mutation that develop prefibrillar tau-aggregates. Our data suggest that progression of the tauopathy can be prevented by administration of lithium when the first signs of neuropathology appear. Further, it is possible to partially reverse tau pathology in advanced stages of the disease, although the presence of already assembled neurofibrillary tangle-like structures cannot be reversed. © 2013 The authors and IOS Press. All rights reserved. |
| publishDate |
2012 |
| dc.date.none.fl_str_mv |
2012 2015 2015 2015 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 |
| format |
article |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/115958 |
| url |
http://hdl.handle.net/10261/115958 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869416590111408128 |
| score |
15,811543 |